Literature DB >> 7213342

The covalent nature of the human antithrombin III--thrombin bond.

M O Longas, T H Finlay.   

Abstract

1. Cleavage of the human antithrombin III--thrombin complex with [14C]methoxyamine hydrochloride results in inactive thrombin and 14C-labelled antithrombin III. 2. Discontinuous polyacrylamide-gel electrophoresis of the reduced dissociation fragments of the complex in the presence of sodium dodecyl sulphate reveals two antithrombin III bands that do not resolve during electrophoresis without reduction. The heavy band has the electrophoretic mobility of the native protein. The light band has an apparent mol.wt. that is approx. 4000 less than the molecular weight of native antithrombin III. 3. Treatment of the cleavage products of the complex with carboxypeptidase B yields 1 mumol of arginine, a new C-terminal amino acid, per mumol of thrombin dissociated. The results indicate that during formation of the antithrombin III--thrombin complex, the inhibitor is cleaved at an arginine--X bond; this arginine residue forms a carboxylic ester with the enzyme, while the excised polypeptide remains bound through a disulphide bridge(s).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7213342      PMCID: PMC1162028          DOI: 10.1042/bj1890481

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  Primary structure of human prethrombin 2 and alpha-thrombin.

Authors:  R J Butkowski; J Elion; M R Downing; K G Mann
Journal:  J Biol Chem       Date:  1977-07-25       Impact factor: 5.157

2.  On the complex formation of antithrombin 3 with thrombin. Gelfiltration studies on human plasma and serum.

Authors:  B Binder
Journal:  Thromb Diath Haemorrh       Date:  1973-11

3.  The purification and mechanism of action of human antithrombin-heparin cofactor.

Authors:  R D Rosenberg; P S Damus
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Amino acid analysis: aqueous dimethyl sulfoxide as solvent for the ninhydrin reaction.

Authors:  S Moore
Journal:  J Biol Chem       Date:  1968-12-10       Impact factor: 5.157

6.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

7.  Heparin cofactor activity measured with an amidolytic method.

Authors:  O R Odegard; M Lie; U Abildgaard
Journal:  Thromb Res       Date:  1975-04       Impact factor: 3.944

8.  Quantitation of thrombin-antithrombin III complexes in human blood.

Authors:  D Collen; F de Cock; M Verstraete
Journal:  Eur J Clin Invest       Date:  1977-10       Impact factor: 4.686

9.  Human thrombins. Production, evaluation, and properties of alpha-thrombin.

Authors:  J W Fenton; M J Fasco; A B Stackrow
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

10.  Evidence for the formation of an ester between thrombin and heparin cofactor.

Authors:  W G Owen
Journal:  Biochim Biophys Acta       Date:  1975-10-20
View more
  11 in total

1.  Structural similarity of the covalent complexes formed between the serpin plasminogen activator inhibitor-1 and the arginine-specific proteinases trypsin, LMW u-PA, HMW u-PA, and t-PA: use of site-specific fluorescent probes of local environment.

Authors:  Marija Backovic; Efstratios Stratikos; Daniel A Lawrence; Peter G W Gettins
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

2.  Antithrombin III Milano 2: a single base substitution in the thrombin binding domain detected with PCR and direct genomic sequencing.

Authors:  R J Olds; D Lane; R Caso; A Tripodi; P M Mannucci; S L Thein
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

3.  Formation, characterization and detection of a ternary complex between S protein, thrombin and antithrombin III in serum.

Authors:  K T Preissner; L Zwicker; G Müller-Berghaus
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

Review 4.  Aspects of C1-inhibitor biochemistry and pathophysiology.

Authors:  T K Nilsson
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

5.  Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin.

Authors:  A Danielsson; I Björk
Journal:  Biochem J       Date:  1983-08-01       Impact factor: 3.857

Review 6.  Mechanism of the anticoagulant action of heparin.

Authors:  I Björk; U Lindahl
Journal:  Mol Cell Biochem       Date:  1982-10-29       Impact factor: 3.396

7.  SERPINB12 Is a Slow-Binding Inhibitor of Granzyme A and Hepsin.

Authors:  Jason Z Niehaus; Mark T Miedel; Misty Good; Allyson N Wyatt; Stephen C Pak; Gary A Silverman; Cliff J Luke
Journal:  Biochemistry       Date:  2015-11-05       Impact factor: 3.162

8.  Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.

Authors:  T Koide; S Odani; K Takahashi; T Ono; N Sakuragawa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

9.  Mechanism of inactivation of trypsin by antithrombin.

Authors:  A Danielsson; I Björk
Journal:  Biochem J       Date:  1982-10-01       Impact factor: 3.857

10.  In vitro and in vivo characterization of a reversible synthetic heparin analog.

Authors:  Matthew F Whelihan; Brian Cooley; Yongmei Xu; Rafal Pawlinski; Jian Liu; Nigel S Key
Journal:  Thromb Res       Date:  2015-12-10       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.